Draft, Do Not Distribute
1 Draft EEVs SMPR V4
AOAC SMPR 2015.XXX; Version 5, June 19, 2015
1
2
Method Name:
Identification of Venezuelan Equine Encephalitis Virus (VEEV)
3
4
Approved Body:
AOAC Stakeholder Panel on Agent Detection Assays
5
6
1.
Intended Use
:
Laboratory or field use by Department of Defense trained operators.
7
8
2.
Applicability
:
Identification of VEEV in liquid samples from aerosol collectors.
The
9
preferential method would be a field-deployable assay.
10
11
12
3.
Analytical Technique
:
Molecular methods of detecting target-specific viral component(s).
13
14
4.
Definitions
:
15
16
Acceptable Minimum Identification Level (AMIL)
17
The predetermined minimum level of an analyte, as specified by an expert committee which
18
must be detected and identified by the candidate method with a specified probability of
19
identification (POI).
20
21
Exclusivity
22
Study involving pure non-target strains and species, which are potentially cross-reactive,
23
that shall not be detected or identified by the test method.
24
25
Inclusivity
26
Study involving pure target strains or species that shall be detected and identified by the
27
alternative method.
28
29
Maximum Time-To-Assay Result
30
Maximum time to complete an analysis starting from the test portion preparation to assay
31
result.
32
33
Probability of Identification (POI)
34
The proportion of positive analytical outcomes for an identification method for a given
35
matrix at a given analyte level or concentration.
36
37
38
Venezuelan Equine Encephalitis(VEE) Virus
(VEEV)
VEEV encompasses several viruses all
39
of which are within the Alphavirus genus of the
Togaviridae
family. For the purpose of this
40
SMPR VEEV includes the human pathogenic virus variants VEEV-1AB, VEEV-1C, VEEV-1D, and
41
VEE-1D.
42
43
5.
System suitability tests and/or analytical quality control:
44
The controls listed in Table I shall be made available in assays as appropriate. Manufacturer
45
must provide written justification if controls are not available with the assay.
46
47